Allorion Therapeutics
Allorion Therapeutics. Pioneering Precision in Healthcare
Guangzhou, United States · Founded 2020 · $40.0M raised
- Headquarters
- Guangzhou
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- alloriontx.com
- Total Funding
- $40.0M
- Last Round
- $40.0M Series ADec 2021
- Rounds
- 1
About
Allorion Therapeutics is a clinical-stage biotechnology company developing novel small molecule drugs against cancer and autoimmune diseases. Founded in 2020, the company operates R&D facilities in Guangzhou, China and Boston, USA, leveraging innovative discovery platforms to create globally competitive targeted therapies.
Summary
Allorion Therapeutics is a Biotech company based in Guangzhou, United States, founded in 2020. It has raised $40.0M in total across 1 round, most recently a $40.0M Series A round in Dec 2021. Investors include Qiming VP.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2021
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...